264 related articles for article (PubMed ID: 24267002)
1. [The variation and clinical significance of paroxysmal nocturnal hemoglobinuria clone in patients with aplastic anemia before and after immunosuppressive therapy].
Sun YX; Zhu MQ; He GS; Wang XL; Fang BZ; Lu C; Liu ZZ; Wu Q; Yang Y; Wu DP; Sun AN
Zhonghua Nei Ke Za Zhi; 2013 Jul; 52(7):585-9. PubMed ID: 24267002
[TBL] [Abstract][Full Text] [Related]
2. [The clinical significance of evolution of paroxysmal nocturnal haemoglobinuria clones in aplastic anemia patients].
Li YM; Li XX; Ge ML; Shi J; Shao YQ; Qian LS; Zheng YZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):117-22. PubMed ID: 22730662
[TBL] [Abstract][Full Text] [Related]
3. The role of paroxysmal nocturnal hemoglobinuria clones in response to immunosuppressive therapy of patients with severe aplastic anemia.
Zhao X; Zhang L; Jing L; Zhou K; Li Y; Peng G; Ye L; Li Y; Li J; Fan H; Song L; Yang W; Zhang F
Ann Hematol; 2015 Jul; 94(7):1105-10. PubMed ID: 25784221
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study.
Kulagin A; Lisukov I; Ivanova M; Golubovskaya I; Kruchkova I; Bondarenko S; Vavilov V; Stancheva N; Babenko E; Sipol A; Pronkina N; Kozlov V; Afanasyev B
Br J Haematol; 2014 Feb; 164(4):546-54. PubMed ID: 24261566
[TBL] [Abstract][Full Text] [Related]
5. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: a single-center experience.
Li Y; Li X; Ge M; Shi J; Qian L; Zheng Y; Wang J
Ann Hematol; 2011 May; 90(5):529-37. PubMed ID: 21207031
[TBL] [Abstract][Full Text] [Related]
7. Significance of paroxysmal nocturnal hemoglobinuria clone in immunosuppressive therapy for children with severe aplastic anemia.
Li J; Zong SY; Yin ZX; Gao YY; Liu LP; Wan Y; Lan Y; Gong XW; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Mar; 24(3):303-308. PubMed ID: 35351262
[TBL] [Abstract][Full Text] [Related]
8. Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia.
Pu JJ; Mukhina G; Wang H; Savage WJ; Brodsky RA
Eur J Haematol; 2011 Jul; 87(1):37-45. PubMed ID: 21447004
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus as an alternative to cyclosporine in the maintenance phase of immunosuppressive therapy for severe aplastic anemia in children.
Alsultan A; Goldenberg NA; Kaiser N; Graham DK; Hays T
Pediatr Blood Cancer; 2009 May; 52(5):626-30. PubMed ID: 19148946
[TBL] [Abstract][Full Text] [Related]
10. [Detection of PNH clones using flow cytometry in aplastic anemia and paroxysmal nocturnal hemoglobinuria].
Forés R; Alcocer M; Cabrera R; Sanjuán I; Briz M; Lago C; Fernández MN
Sangre (Barc); 1999 Jun; 44(3):199-203. PubMed ID: 10481581
[TBL] [Abstract][Full Text] [Related]
11. Screening for paroxysmal nocturnal hemoglobinuria (PNH) clone in Egyptian children with aplastic anemia.
Rizk S; Ibrahim IY; Mansour IM; Kandil D
J Trop Pediatr; 2002 Jun; 48(3):132-7. PubMed ID: 12164595
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and treatment of aquired aplastic anemia].
Kulagin AD; Lisukov IA; Kriuchkova IV; Sizikova SA; Gilevich AV; Denisova VV; Filimonov PN; Meniaeva EV; Pronkina NV; Kozhevnikov VS; Chernykh ER; Kozlov VA
Ter Arkh; 2006; 78(11):48-54. PubMed ID: 17195527
[TBL] [Abstract][Full Text] [Related]
13. Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine.
Scheinberg P; Marte M; Nunez O; Young NS
Haematologica; 2010 Jul; 95(7):1075-80. PubMed ID: 20595102
[TBL] [Abstract][Full Text] [Related]
14. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of immunosuppressive therapy for children with aplastic anemia].
Wang YC; Yin CY; Feng L; Wang CM; Ma LN; Wei YW; Sheng GY
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Jan; 14(1):33-7. PubMed ID: 22289749
[TBL] [Abstract][Full Text] [Related]
16. Relationship between immune status after ATG treatment and PNH clone evolution in patients with severe aplastic anemia.
Wang H; Liu H; Wang T; Li L; Liu C; Li L; Chen T; Qi W; Ding K; Fu R
J Clin Lab Anal; 2021 Mar; 35(3):e23667. PubMed ID: 33249661
[TBL] [Abstract][Full Text] [Related]
17. [Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].
Chen C; Fang JP; Huang SL; Zhong FY
Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):841-4. PubMed ID: 17274875
[TBL] [Abstract][Full Text] [Related]
18. Development of clinical paroxysmal nocturnal haemoglobinuria in children with aplastic anaemia.
Narita A; Muramatsu H; Okuno Y; Sekiya Y; Suzuki K; Hamada M; Kataoka S; Ichikawa D; Taniguchi R; Murakami N; Kojima D; Nishikawa E; Kawashima N; Nishio N; Hama A; Takahashi Y; Kojima S
Br J Haematol; 2017 Sep; 178(6):954-958. PubMed ID: 28643364
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive therapy for acquired severe aplastic anemia (SAA): a prospective comparison of four different regimens.
Zheng Y; Liu Y; Chu Y
Exp Hematol; 2006 Jul; 34(7):826-31. PubMed ID: 16797409
[TBL] [Abstract][Full Text] [Related]
20. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
